Drospirenone

Generic Name
Drospirenone
Brand Names
Angeliq 0.25/0.5 28 Day, Beyaz 28 Day, Gianvi 28-day, Jasmiel 28 Day, Lo-zumandimine 28 Day, Loryna, Nextstellis 28 Day, Nikki 28 Day, Ocella 28 Day, Safyral 28 Day, Slynd, Syeda 28 Day, Tydemy 28 Day, Vestura, Yasmin, Yasmin 28 Day, Yaz 28 Day, Yaz Plus, Zarah, Zumandimine 28 Day
Drug Type
Small Molecule
Chemical Formula
C24H30O3
CAS Number
67392-87-4
Unique Ingredient Identifier
N295J34A25
Background

Drospirenone is a synthetic progestin commonly found in the popular oral contraceptive, Yaz in combination with Ethinyl estradiol. Most recently, it was approved by both Health Canada and the FDA in combination with Estetrol as an oral contraceptive therapy. Aside from its contraceptive effects, drospirenone is used with estrogens to control acne and premens...

Indication

Drospirenone, in combination with ethinyl estradiol or estetrol, is indicated as an oral contraceptive for the prevention of pregnancy. In addition to its use for contraceptive effects, this combination is used to treat moderate acne vulgaris and the symptoms of premenstrual dysphoric disorder. The drug has approved indications for combination with estrogens...

Associated Conditions
Atrophy of vulva, Moderate to Severe Vasomotor Symptoms, Neural Tube Defects (NTDs), Premenstrual Dysphoric Disorder (PMDD), Vulvo Vaginal Atrophy, Moderate Acne vulgaris
Associated Therapies
Contraception, Folate supplementation therapy
business-standard.com
·

Pharma stocks: Nomura gives 'Buy' to Lupin remains 'Neutral' on others

Indian pharma giants focus on quality over quantity, with complex product filings increasing. US generics sales show slight growth, and regulatory challenges ease. Nomura recommends Lupin for its upcoming launches and stable market shares, while noting setbacks. Sun Pharma's specialty segment growth slows, and Dr Reddy's faces market share declines. Cipla and Zydus Lifesciences show growth but face inspection and competition challenges.
© Copyright 2024. All Rights Reserved by MedPath